pd 145065 has been researched along with angiotensin ii in 10 studies
| Studies (pd 145065) | Trials (pd 145065) | Recent Studies (post-2010) (pd 145065) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 76 | 1 | 5 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | pd 145065 (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 9 (90.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, WB; Hanke, CJ; Rosolowsky, LJ | 1 |
| Calaghan, SC; White, E | 1 |
| Beshara, G; Ghali, R; Sabra, R; Serhal, H; Sharaf, LH; Zeinoun, N | 1 |
| Cachofeiro, V; Cediel, E; de las Heras, N; Lahera, V; Navarro-Cid, J; Sanz-Rosa, D; Vázquez-Cruz, B | 1 |
| Kadekaro, M; Salas, N; Summy-Long, JY; Terrell, ML | 1 |
| Bartoli, E; Bergamasco, L; Castello, L; Letizia, C; Sainaghi, PP | 2 |
| Chong, T; Ramirez, R; Victorino, GP | 1 |
| Castro-Chaves, P; Leite-Moreira, AF; Roncon-Albuquerque, R | 1 |
| Castro-Chaves, P; Fontes-Carvalho, R; Leite-Moreira, AF; Pimentel-Nunes, P; Pintalhao, M | 1 |
10 other study(ies) available for pd 145065 and angiotensin ii
| Article | Year |
|---|---|
Adrenal capillary endothelial cells stimulate aldosterone release through a protein that is distinct from endothelin.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Bradykinin; Capillaries; Cattle; Coculture Techniques; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Hormone Antagonists; Oligopeptides; Osmolar Concentration; Pronase; Receptor, Endothelin B; Steroids; Time Factors; Zona Fasciculata; Zona Glomerulosa | 1999 |
Contribution of angiotensin II, endothelin 1 and the endothelium to the slow inotropic response to stretch in ferret papillary muscle.
Topics: Angiotensin II; Animals; Endothelin-1; Endothelium; Female; Ferrets; Kinetics; Losartan; Male; Muscle Spindles; Myocardial Contraction; Octoxynol; Oligopeptides; Papillary Muscles; Peptides, Cyclic; Saralasin | 2001 |
Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity.
Topics: Amphotericin B; Angiotensin II; Animals; Antifungal Agents; Arginine; Candida albicans; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Endothelins; Glomerular Filtration Rate; Imidazoles; In Vitro Techniques; Injections, Intravenous; Kidney Diseases; Liposomes; Male; Nitric Oxide; Nitroso Compounds; Oligopeptides; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 2001 |
Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Male; Oligopeptides; Oxazoles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Endothelin; Receptors, Thromboxane A2, Prostaglandin H2; Renal Circulation; Thromboxane A2; Vascular Resistance; Vasoconstriction | 2002 |
Role of prostaglandin, endothelin and sympathetic nervous system on the L-NAME-induced pressor responses in spontaneously hypertensive rats.
Topics: Acetamides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chlorisondamine; Cyclooxygenase Inhibitors; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Ganglionic Blockers; Heart Rate; Indomethacin; Injections, Intraventricular; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oligopeptides; Prostaglandins; Rats; Rats, Inbred SHR; Sympathetic Nervous System | 2003 |
Pathways of glomerular toxicity of cyclosporine-A: an "in vitro" study.
Topics: Angiotensin I; Angiotensin II; Animals; Cyclosporine; Endothelin-1; Female; Kidney Glomerulus; Oligopeptides; Organ Culture Techniques; Peptides, Cyclic; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Time Factors | 2005 |
Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor.
Topics: Angiotensin II; Animals; Capillary Permeability; Drug Interactions; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Female; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 2006 |
Endothelin ETA receptors and endothelium partially mediate the positive inotropic and lusitropic effects of angiotensin II.
Topics: Angiotensin II; Animals; Dose-Response Relationship, Drug; Endothelium; Losartan; Muscle Contraction; Muscles; Myocardial Contraction; Myocardium; Oligopeptides; Rabbits; Receptor, Endothelin A; Receptors, Endothelin | 2006 |
In vitro effect of cyclosporine-A on angiotensins secretion by glomerular cells.
Topics: Angiotensin I; Angiotensin II; Animals; Cyclosporine; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Female; Immunosuppressive Agents; Kidney Glomerulus; Oligopeptides; Peptides, Cyclic; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Time Factors; Tissue Culture Techniques; Up-Regulation | 2008 |
Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart.
Topics: Acetophenones; Angiotensin II; Animals; Diastole; Dose-Response Relationship, Drug; Endocardium; Endothelin Receptor Antagonists; Endothelin-1; Endothelium; Enzyme Inhibitors; In Vitro Techniques; Male; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Papillary Muscles; Peptides, Cyclic; Rabbits; Receptors, Endothelin | 2009 |